Plastic Pipe Market
Description
Plastic Pipe Market Summary
The global plastic pipe market size was estimated at USD 72.96 billion in 2025 and is projected to reach USD 117.92 billion by 2033, growing at a CAGR of 6.1% from 2026 to 2033. The rising demand for plastic pipes across applications, including sewage systems, water supply, drainage, and irrigation, is owing to rapid urbanization and industrialization across several economies.
Growth of the plastic pipe industry is primarily driven by the boom in shale gas exploration and production, with applications across oil and gas extraction, transportation, and distribution. In addition, water scarcity and the need for efficient water management are significant concerns. Plastic pipes play a crucial role in water distribution, irrigation, and drainage systems. The rising focus on infrastructure renewal and development, as highlighted by expansion initiatives such as acquisitions and mergers, is expected to propel construction activity across the country, thereby boosting market growth.
Moreover, the introduction of innovative technologies for the manufacture of PVC pipes using molecular orientation is also a major trend in the U.S. plastic pipe market. Innovative PVC pipes with IoT technology enable real-time monitoring of water flow, pressure, and temperature, helping detect leaks and other issues early.
Global Plastic Pipe Market Report Segmentation
This report forecasts volume & revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global plastic pipe market report based on material, application, end use, and region:
Material Outlook (Volume, Kilotons, Revenue, USD Million, 2021 - 2033) Polyvinyl Chloride Polypropylene Polyethylene Others Application Type Outlook (Volume, Kilotons, Revenue, USD Million, 2021 - 2033) Irrigation Water Supply Sewerage Plumbing HVAC Others End Use Outlook (Volume, Kilotons, Revenue, USD Million, 2021 - 2033) Building & Construction Agriculture Oil & Gas Others Regional Outlook (Volume, Kilotons, Revenue, USD Million, 2021 - 2033) North America U.S. Canada Mexico Europe Germany France UK Italy Spain Asia Pacific China Japan South Korea India Central & South America Brazil Argentina Middle East & Africa Saudi Arabia UAE South Africa Please note The report will be delivered in 2-3 business days upon order notification.
The global plastic pipe market size was estimated at USD 72.96 billion in 2025 and is projected to reach USD 117.92 billion by 2033, growing at a CAGR of 6.1% from 2026 to 2033. The rising demand for plastic pipes across applications, including sewage systems, water supply, drainage, and irrigation, is owing to rapid urbanization and industrialization across several economies.
Growth of the plastic pipe industry is primarily driven by the boom in shale gas exploration and production, with applications across oil and gas extraction, transportation, and distribution. In addition, water scarcity and the need for efficient water management are significant concerns. Plastic pipes play a crucial role in water distribution, irrigation, and drainage systems. The rising focus on infrastructure renewal and development, as highlighted by expansion initiatives such as acquisitions and mergers, is expected to propel construction activity across the country, thereby boosting market growth.
Moreover, the introduction of innovative technologies for the manufacture of PVC pipes using molecular orientation is also a major trend in the U.S. plastic pipe market. Innovative PVC pipes with IoT technology enable real-time monitoring of water flow, pressure, and temperature, helping detect leaks and other issues early.
Global Plastic Pipe Market Report Segmentation
This report forecasts volume & revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global plastic pipe market report based on material, application, end use, and region:
Table of Contents
120 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Drug Type
- 1.2.3. Therapeutic Use
- 1.2.4. End Use
- 1.3. Estimation and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR’s Internal Database
- 1.5.3. Secondary Materials & Third-Party Perspectives
- 1.5.4. Primary Research
- 1.6. Information or Data Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Validation
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.8.1.1. Research Scope and Assumptions
- 1.8.1.2. Research Methodology and Assumptions
- 1.8.2. Volume Price Analysis
- 1.8.3. CDMO Pen and Injector Drug Delivery Devices Market
- 1.9. List of Secondary Sources
- 1.10. List of Abbreviations
- 1.11. Objectives
- 1.11.1. Objective 1
- 1.11.2. Objective 2
- 1.11.3. Objective 3
- Chapter 2. Executive Summary
- 2.1. Market Snapshot (Regional)
- 2.2. Segment Snapshot (Product)
- 2.3. Segment Snapshot (Therapeutic Use)
- 2.4. Segment Snapshot (End Use)
- 2.5. Market Concentration
- Chapter 3. Pen and Injector Drug Delivery Devices Market Variables and Trends Market Lineage Outlook
- 3.1. Market Dynamics
- 3.1.1. Market Driver Impact Analysis
- 3.1.2. Market Restraint Analysis
- 3.1.3. Market Opportunity Analysis
- 3.2. Industry Analysis Tools
- 3.2.1. Porter’s Five Forces Analysis
- 3.2.2. Macroeconomic Analysis
- 3.3. List of CDMO Manufacturers and Supplied Pen and Injector Drug Delivery Devices to Companies
- 3.4. List of In-House Manufacturers of Pen and Injector Drug Delivery Devices
- 3.5. Qualitative Insights on Potential Impact of New Injectables or Oral Drugs and Development of Multi-Dose Devices, by Region
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia
- 3.6. Global CDMO Pen and Injector Drug Delivery Devices Market, by Product, 2021-2033 (value in USD Billion and Volume in Units Sold)
- 3.6.1. Global CDMO Pen and Injector Drug Delivery Devices Market, by Product, 2021- 2033 (USD Billion)
- 3.6.2. Global CDMO Pen and Injector Drug Delivery Devices Market, by Product, 2021- 2033 (Units)
- Chapter 4. Pen and Injector Drug Delivery Devices Market: Product Analysis
- 4.1. Product Movement Analysis & Market Share, 2025 & 2033
- 4.2. Pen and Injector Drug Delivery Devices Market Estimates & Forecast, by Product (USD Billion, Units)
- 4.3. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 4.3.1. Injectors
- 4.3.1.1. Injectors Market, 2021 - 2033 (USD Billion, Units)
- 4.3.1.2. GLP-1 Agonists
- 4.3.1.2.1. GLP-1 Agonists Market, 2021 to 2033 (USD Billion, Units)
- 4.3.1.3. Hormone Therapies
- 4.3.1.3.1. Hormone Therapies Market, 2021 to 2033 (USD Billion, Units)
- 4.3.1.4. Biologics
- 4.3.1.4.1. Biologics Market, 2021 to 2033 (USD Billion, Units)
- 4.3.1.5. Others
- 4.3.1.5.1. Others Market, 2021 to 2033 (USD Billion, Units)
- 4.3.2. Pen
- 4.3.2.1. Pens Market, 2021 - 2033 (USD Billion, Units)
- 4.3.2.2. GLP-1 Agonists
- 4.3.2.2.1. GLP-1 Agonists Market, 2021 to 2033 (USD Billion, Units)
- 4.3.2.3. Insulin
- 4.3.2.3.1. Insulin Market, 2021 to 2033 (USD Billion, Units)
- 4.3.2.4. Hormone Therapies
- 4.3.2.4.1. Hormone Therapies Market, 2021 to 2033 (USD Billion, Units)
- 4.3.2.5. Others
- 4.3.2.5.1. Other Market Estimates & Forecasts, 2021 to 2033 (USD Billion, Units)
- Chapter 5. Pen and Injector Drug Delivery Devices Market: Therapeutic Use Estimates & Trend Analysis
- 5.1. Therapeutic Area Movement Analysis & Market Share, 2025 & 2033
- 5.2. Pen and Injector Drug Delivery Devices Market Estimates & Forecast, by Therapeutic Use (USD Billion, Units)
- 5.3. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 5.3.1. Autoimmune Disorders
- 5.3.1.1. Autoimmune Disorders Market, 2021 to 2033 (USD Billion, Units)
- 5.3.2. Hormonal Disorders
- 5.3.2.1. Hormonal Disorders Market, 2021 to 2033 (USD Billion, Units)
- 5.3.3. Oncology
- 5.3.3.1. Oncology Market, 2021 to 2033 (USD Billion, Units)
- 5.3.4. Obesity
- 5.3.4.1. Obesity Market, 2021 to 2033 (USD Billion, Units)
- 5.3.5. Diabetes Mellitus
- 5.3.5.1. Diabetes Mellitus Market, 2021 to 2033 (USD Billion, Units)
- 5.3.6. Others
- 5.3.6.1. Others Market, 2021 to 2033 (USD Billion, Units)
- Chapter 6. Pen and Injector Drug Delivery Devices Market: End Use Analysis
- 6.1. End Use Movement Analysis & Market Share, 2025 & 2033
- 6.2. Pen and Injector Drug Delivery Devices Market Estimates & Forecast, by End Use (USD Billion, Units)
- 6.3. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 6.3.1. Hospitals
- 6.3.1.1. Hospitals Market, 2021 to 2033 (USD Billion, Units)
- 6.3.2. Homecare Settings
- 6.3.2.1. Homecare Settings Market, 2021 to 2033 (USD Billion, Units)
- 6.3.3. Others
- 6.3.3.1. Others Market, 2021 to 2033 (USD Billion, Units)
- Chapter 7. Pen and Injector Drug Delivery Devices Market: Regional Estimates & Trend Analysis
- 7.1. Pen and Injector Drug Delivery Devices Market: Regional Outlook
- 7.2. North America
- 7.2.1. North America Pen and Injector Drug Delivery Devices Market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
- 7.2.2. U.S.
- 7.2.2.1. Competitive Scenario
- 7.2.2.2. Regulatory framework
- 7.2.2.3. Reimbursement Structure
- 7.2.2.4. U.S. Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.2.3. Canada
- 7.2.3.1. Competitive Scenario
- 7.2.3.2. Regulatory framework
- 7.2.3.3. Reimbursement Structure
- 7.2.3.4. Canada Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.2.4. Mexico
- 7.2.4.1. Competitive Scenario
- 7.2.4.2. Regulatory framework
- 7.2.4.3. Reimbursement Structure
- 7.2.4.4. Mexico Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.3. Europe
- 7.3.1. Europe Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.3.2. UK
- 7.3.2.1. Competitive Scenario
- 7.3.2.2. Regulatory framework
- 7.3.2.3. Reimbursement Structure
- 7.3.2.4. UK Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.3.3. Germany
- 7.3.3.1. Competitive Scenario
- 7.3.3.2. Regulatory framework
- 7.3.3.3. Reimbursement Structure
- 7.3.3.4. Germany Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.3.4. France
- 7.3.4.1. Competitive Scenario
- 7.3.4.2. Regulatory framework
- 7.3.4.3. Reimbursement Structure
- 7.3.4.4. France Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.3.5. Italy
- 7.3.5.1. Competitive Scenario
- 7.3.5.2. Regulatory framework
- 7.3.5.3. Reimbursement Structure
- 7.3.5.4. Italy Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.3.6. Spain
- 7.3.6.1. Competitive Scenario
- 7.3.6.2. Regulatory framework
- 7.3.6.3. Reimbursement Structure
- 7.3.6.4. Spain Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.3.7. Norway
- 7.3.7.1. Competitive Scenario
- 7.3.7.2. Regulatory framework
- 7.3.7.3. Reimbursement Structure
- 7.3.7.4. Norway Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.3.8. Sweden
- 7.3.8.1. Competitive Scenario
- 7.3.8.2. Regulatory framework
- 7.3.8.3. Reimbursement Structure
- 7.3.8.4. Sweden Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.3.9. Denmark
- 7.3.9.1. Competitive Scenario
- 7.3.9.2. Regulatory framework
- 7.3.9.3. Reimbursement Structure
- 7.3.9.4. Denmark Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.4. Asia
- 7.4.1. Asia Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.4.2. China
- 7.4.2.1. Competitive Scenario
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Reimbursement Structure
- 7.4.2.4. China Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.4.3. Japan
- 7.4.3.1. Competitive Scenario
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Reimbursement Structure
- 7.4.3.4. Japan Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.4.4. India
- 7.4.4.1. Competitive Scenario
- 7.4.4.2. Regulatory framework
- 7.4.4.3. Reimbursement Structure
- 7.4.4.4. India Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.4.5. Thailand
- 7.4.5.1. Competitive Scenario
- 7.4.5.2. Regulatory framework
- 7.4.5.3. Reimbursement Structure
- 7.4.5.4. Thailand Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.4.6. South Korea
- 7.4.6.1. Competitive Scenario
- 7.4.6.2. Regulatory framework
- 7.4.6.3. Reimbursement Structure
- 7.4.6.4. South Korea Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.4.7. Saudi Arabia
- 7.4.7.1. Competitive Scenario
- 7.4.7.2. Regulatory framework
- 7.4.7.3. Reimbursement Structure
- 7.4.7.4. Saudi Arabia Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.4.8. UAE
- 7.4.8.1. Competitive Scenario
- 7.4.8.2. Regulatory framework
- 7.4.8.3. Reimbursement Structure
- 7.4.8.4. UAE Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- 7.4.9. Kuwait
- 7.4.9.1. Competitive Scenario
- 7.4.9.2. Regulatory framework
- 7.4.9.3. Reimbursement Structure
- 7.4.9.4. Kuwait Pen and Injector Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
- Chapter 8. Pen and Injector Drug Delivery Devices Market: Competitive Analysis
- 8.1. Company Categorization
- 8.2. Participant’s Overview
- 8.3. Financial Performance
- 8.4. Product Offerings
- 8.5. Company Market Position Analysis
- 8.6. Company Market Share Analysis, 2024 (%)
- 8.7. Strategy Mapping
- 8.7.1. Product Launches & Approvals
- 8.7.2. Partnerships & Collaborations
- 8.7.3. Mergers & Acquisitions
- 8.7.4. Expansions
- 8.7.5. Others
- 8.8. Company Profiles
- 8.8.1. Novo Nordisk A/S
- 8.8.1.1. Company Overview
- 8.8.1.2. Financial Performance
- 8.8.1.3. Product Benchmarking
- 8.8.1.4. Strategic Initiatives
- 8.8.2. Sanofi
- 8.8.2.1. Company Overview
- 8.8.2.2. Financial Performance
- 8.8.2.3. Product Benchmarking
- 8.8.2.4. Strategic Initiatives
- 8.8.3. Eli Lilly and Company
- 8.8.3.1. Company Overview
- 8.8.3.2. Financial Performance
- 8.8.3.3. Product Benchmarking
- 8.8.3.4. Strategic Initiatives
- 8.8.4. AstraZeneca plc
- 8.8.4.1. Company Overview
- 8.8.4.2. Financial Performance
- 8.8.4.3. Product Benchmarking
- 8.8.4.4. Strategic Initiatives
- 8.8.5. Pfizer, Inc.
- 8.8.5.1. Company Overview
- 8.8.5.2. Financial Performance
- 8.8.5.3. Product Benchmarking
- 8.8.5.4. Strategic Initiatives
- 8.8.6. Merck KGaA
- 8.8.6.1. Company Overview
- 8.8.6.2. Financial Performance
- 8.8.6.3. Product Benchmarking
- 8.8.6.4. Strategic Initiatives
- 8.8.7. Teva Pharmaceuticals
- 8.8.7.1. Company Overview
- 8.8.7.2. Financial Performance
- 8.8.7.3. Product Benchmarking
- 8.8.7.4. Strategic Initiatives
- 8.8.8. Amgen, Inc.
- 8.8.8.1. Company Overview
- 8.8.8.2. Financial Performance
- 8.8.8.3. Product Benchmarking
- 8.8.8.4. Strategic Initiatives
- 8.8.9. Ferring Pharmaceuticals
- 8.8.9.1. Company Overview
- 8.8.9.2. Financial Performance
- 8.8.9.3. Product Benchmarking
- 8.8.9.4. Strategic Initiatives
- 8.8.10. AbbVie, Inc.
- 8.8.10.1. Company Overview
- 8.8.10.2. Financial Performance
- 8.8.10.3. Product Benchmarking
- 8.8.10.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
